Valeant board debating Pearson's return as health improves: CNBC
(Reuters) - The health of Valeant Pharmaceuticals International Inc's Michael Pearson is improving, the company said on Thursday, but CNBC reported that there was debate within the board over whether he was ready to return to work.
No comments:
Post a Comment